Amendment to Regulation (EC) No 1206/2005
Article 18
In the Annex to Regulation (EC) No 1206/2005, entry E 1633 ‘on Endo-1,3(4)-beta-glucanase EC 3.2.1.6, Endo-1,4-beta-xylanase EC 3.2.1.8 and Subtilisin and EC 3.4.21.62’ is deleted.
Commission Implementing Regulation (EU) 2017/1145 Article 18
Commission Implementing Regulation (EU) 2017/1145 Article 18
Other provisions in Commission Implementing Regulation (EU) 2017/1145
- Article 13: Amendment to Regulation (EC) No 255/2005
- Article 14: Amendment to Regulation (EC) No 358/2005
- Article 15: Amendment to Regulation (EC) No 521/2005
- Article 16: Amendment to Regulation (EC) No 600/2005
- Article 17: Amendment to Regulation (EC) No 943/2005
- Article 19: Amendment to Regulation (EC) No 1458/2005
- Article 20: Amendment to Regulation (EC) No 1810/2005
- Article 21: Amendment to Regulation (EC) No 1811/2005
- Article 22: Amendment to Regulation (EC) No 2036/2005
- Article 23: Amendment to Regulation (EC) No 252/2006
CitationArticle 18 of Commission Implementing Regulation (EU) 2017/1145 (LawPlayer, data as of 2026-07-04)
© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.
What to look at next
Commission Implementing Regulation (EU) 2017/1145, full textThe complete text of this law, so you can read this section in contextEuropean Union legislationEU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and yearEuropean Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview